The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Fibromyalgia: Understanding, Diagnosis and Modern Approaches to Treatment
Abstract
Fibromyalgia (FM) is a chronic condition characterized by generalized musculoskeletal pain associated with other symptoms, especially sleep and mood disorders, fatigue, and cognitive dysfunctions. The etiopathogenesis of FM is not sufficiently known, and regardless of numerous research, the clinical presentation is nonspecific, which makes it difficult to approve a timely diagnosis and, subsequently, an adequate therapeutic approach. Genetic, hormonal, immunological, and environmental factors are cited as potential factors in the development of this condition. Diagnosis is based on a clinical approach and known diagnostic criteria, while additional methods, such as radiographic, magnetic resonance, or laboratory analyses, can be useful to exclude other conditions. The heterogeneity of FM significantly impacts both diagnosis and treatment, as it presents a wide spectrum of symptoms that vary in severity, combinations, and underlying contributing factors. This variability is a challenge for clinicians and requires a holistic, comprehensive, multidisciplinary, patient-centered approach. According to The European League Against Rheumatism (EULAR) from 2016, treatment begins with patient education and involves the simultaneous application of pharmacological and nonpharmacological treatments. The application of only pharmacological or nonpharmacological treatment is most often not successful. Due to differences in pain threshold, psychological factors, and comorbidities, patients may respond differently to the same interventions. Although there is no universal treatment, this review brings up the fact that the timely recognition of symptoms and a tailored treatment with a patient-centered plan can significantly improve the quality of life of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically, however, IC/BPS is anchored to pelvic and lower urinary tract symptoms5,6, whereas FM is described as a systemic syndrome involving widespread pain, fatigue, sleep disturbance, and affective symptoms7,8.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001384 · Cited by 3,478
2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.08.012 · Cited by 2,232
The association of sleep and pain: an update and a path forward
Finan, P. H., Goodin, B. R., & Smith, M. T. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.08.007 · Cited by 1,620
Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08692.2003 · Cited by 893
Pain catastrophizing and neural responses to pain among persons with fibromyalgia
Gracely, R. H. (2004) · Brain · doi:10.1093/brain/awh098 · Cited by 892
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2783 · Cited by 814
The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders
Knezevic, E., Nenic, K., Milanovic, V., & Knezevic, N. N. (2023) · Cells · doi:10.3390/cells12232726 · Cited by 564
Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071100 · Cited by 470
Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression
Bigatti, S. M., Hernandez, A. M., Cronan, T. A., & Rand, K. L. (2008) · Arthritis Care & Research · doi:10.1002/art.23828 · Cited by 402
Sleep Loss Exacerbates Fatigue, Depression, and Pain in Rheumatoid Arthritis
Irwin, M. R., Olmstead, R., Carrillo, C., Sadeghi, N., FitzGerald, J. D., Ranganath, V. K., & Nicassio, P. M. (2012) · Sleep · doi:10.5665/sleep.1742 · Cited by 279
Research works printed but not linked: 87
- Perrot, 2019, Fibromyalgia: A misconnection in a multiconnected world?, Eur. J. Pain, 23, 866, 10.1002/ejp.1367 · DOI
- Meyer, 2002, Myofascial pain syndrome and its suggested role in the pathogenesis and treatment of fibromyalgia syndrome, Curr. Pain Headache Rep., 6, 274, 10.1007/s11916-002-0048-z · DOI
- Deitos, 2018, Defective Endogenous Pain Modulation in Fibromyalgia: A Meta-Analysis of Temporal Summation and Conditioned Pain Modulation Paradigms, J. Pain, 19, 819, 10.1016/j.jpain.2018.01.010 · DOI · Paper page
- Segerdahl, 2015, The dorsal posterior insula subserves a fundamental role in human pain, Nat. Neurosci., 18, 499, 10.1038/nn.3969 · DOI · Paper page
- Lee, 2023, Etiopathogenesis of fibromyalgia, J. Electrodiagn. Neuromuscul. Dis., 25, 1, 10.18214/jend.2022.00227 · DOI
- Collado, 2010, Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: A magnetic resonance spectroscopy study, Arthritis Rheum., 62, 1829, 10.1002/art.27430 · DOI
- Harris, 2008, Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia, Arthritis Rheum., 58, 903, 10.1002/art.23223 · DOI · Paper page
- Lin, 2012, An antinociceptive role for substance P in acid-induced chronic muscle pain, Proc. Natl. Acad. Sci. USA, 109, E76, 10.1073/pnas.1108903108 · DOI
- Chavan, 2017, Mechanisms and therapeutic relevance of neuro-immune communication, Immunity, 46, 927, 10.1016/j.immuni.2017.06.008 · DOI · Paper page
- Favretti, M., Iannuccelli, C., and Di Franco, M. (2023). Pain Biomarkers in Fibromyalgia Syndrome: Current Understanding and Future Directions. Int. J. Mol. Sci., 24. · DOI
- Schank, 2017, Substance P and the Neurokinin-1 Receptor: The New CRF, Int. Rev. Neurobiol., 136, 151, 10.1016/bs.irn.2017.06.008 · DOI
- Navratilova, 2019, Substance P and Inflammatory Pain: Getting It Wrong and Right Simultaneously, Neuron, 101, 353, 10.1016/j.neuron.2019.01.034 · DOI
- Potvin, 2009, Human evidence of a supra-spinal modulating role of dopamine on pain perception, Synapse, 63, 390, 10.1002/syn.20616 · DOI
- Seo, S., Jung, Y.H., Lee, D., Lee, W.J., Jang, J.H., Lee, J.Y., Choi, S.H., Moon, J.Y., Lee, J.S., and Cheon, G.J. (2021). Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET. PLoS ONE, 16. · DOI
- Wang, 2022, Gray Matter Abnormalities in Patients with Chronic Primary Pain: A Coordinate-Based Meta-Analysis, Pain Physician, 25, 1
- 2020, Clinical Manifestations of Trauma Exposure in Fibromyalgia: The Role of Anxiety in the Association Between Posttraumatic Stress Symptoms and Fibromyalgia Status, J. Trauma. Stress, 33, 1082, 10.1002/jts.22550 · DOI
- Thompson, 2023, The indirect effects of recalled trauma severity on pain ratings among people with fibromyalgia: A moderated mediation model, Behav. Med., 50, 211, 10.1080/08964289.2023.2196389 · DOI
- Nassini, 2020, TRPA1 as a therapeutic target for nociceptive pain, Expert Opin. Ther. Targets, 24, 997, 10.1080/14728222.2020.1815191 · DOI · Paper page
- Jensen, 2019, Mechanisms of spinal cord stimulation for the treatment of pain: Still in the dark after 50 years, Eur. J. Pain, 23, 652, 10.1002/ejp.1336 · DOI · Paper page
- Nadim, 2014, Neuromodulation of neurons and synapses, Curr. Opin. Neurobiol., 29, 48, 10.1016/j.conb.2014.05.003 · DOI · Paper page
- Manion, J., Waller, M.A., Clark, T., Massingham, J.N., and Neely, G.G. (2019). Developing Modern Pain Therapies. Front. Neurosci., 13. · DOI
- Liu, 2022, Physiology of pain—A narrative review on the pain pathway and its application in the pain management, Dig. Med. Res., 5, 56, 10.21037/dmr-21-100 · doi:10.21037/dmr-21-100
- Bennett, 2019, The Role of Voltage-Gated Sodium Channels in Pain Signaling, Physiol. Rev., 99, 1079, 10.1152/physrev.00052.2017 · DOI · Paper page
- Lo, 2022, Microstructural Evidence of Neuroinflammation for Psychological Symptoms and Pain in Patients with Fibromyalgia, J. Rheumatol., 49, 942, 10.3899/jrheum.211170 · DOI
- Boneparth, 2021, Epidermal neurite density in skin biopsies from patients with juvenile fibromyalgia, J. Rheumatol., 48, 575, 10.3899/jrheum.200378 · DOI
- Plaghki, 2019, Fibromyalgia syndrome—A laser-evoked potentials study unsupportive of small nerve fibre involvement, Eur. J. Pain, 24, 448
- Bianchi, 2023, Imaging of the peripheral nervous system in nociplastic pain: An ultrasound study in patients with fibromyalgia, J. Neuroimaging, 33, 558, 10.1111/jon.13104 · DOI
- Arnold, 2013, The fibromyalgia family study: A genome-wide linkage scan study, Arthritis Rheum., 65, 1122, 10.1002/art.37842 · DOI
- Kimura, 2021, Effects of Polymorphisms in the Serotonin Transporter Promoter-Linked Polymorphic Region on Postthoracotomy Pain Severity, J. Pain Res., 14, 1389, 10.2147/JPR.S298685 · DOI
- Gerra, 2019, Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers, Mol. Pain, 15, 1744806918819944, 10.1177/1744806918819944 · DOI · Paper page
- Nugraha, B., Anwar, S.L., Gutenbrunner, C., and Korallus, C. (2020). Polymorphisms of brain-derived neurotrophic factor genes are associated with anxiety and body mass index in fibromyalgia syndrome patients. BMC Res. Notes, 13. · DOI
- Lee, 2012, Candidate gene studies of fibromyalgia: A systematic review and meta-analysis, Rheumatol. Int., 32, 417, 10.1007/s00296-010-1678-9 · DOI
- Mamoun Abdelmageid, S., Mousa Alamir, F., Yousif Abdelrahman, H., and Mohamed Abushama, H. (2023). Association of COMT Val158Met Polymorphism with Fibromyalgia in Khartoum State, Sudan. Pain Res. Manag., 7313587. · doi:10.1155/2023/7313578
- Offenbaecher, 1999, Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region, Arthritis Rheum., 42, 2482, 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B · DOI · Paper page
- Ledermann, 2020, 5ʹUTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls—Preliminary evidence, Synapse, 74, e22147, 10.1002/syn.22147 · DOI
- McLean, 2005, Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia, Arthritis Rheum., 52, 3660, 10.1002/art.21372 · DOI · Paper page
- Crofford, 2004, Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome, Brain Behav. Immun., 18, 314, 10.1016/j.bbi.2003.12.011 · DOI · Paper page
- Abeles, 2007, Narrative review: The pathophysiology of fibromyalgia, Ann. Intern. Med., 146, 726, 10.7326/0003-4819-146-10-200705150-00006 · DOI · Paper page
- Atamer, 2023, The relationship between serum leptin, insulin-like growth factor-1, and insulin-like growth factor binding protein-3 levels and clinical parameters in primary fibromyalgia patients, Rev. Assoc. Medica Bras., 69, e20230240, 10.1590/1806-9282.20230240 · DOI
- Deveci, 2020, Relationship between fibromyalgia clinical and laboratory parameters with obesity, Pamukkale Med. J., 13, 207
- Tander, 2007, Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome, Jt. Bone Spine, 74, 477, 10.1016/j.jbspin.2007.01.024 · DOI
- Hulens, 2023, The link between empty sella syndrome, fibromyalgia, and chronic fatigue syndrome: The role of ıncreased cerebrospinal fluid pressure, J. Pain Res., 16, 205, 10.2147/JPR.S394321 · DOI
- Koca, 2020, Relationship of leptin, growth hormone, and insulin-like growth factor levels with body mass index and disease severity in patients with fibromyalgia syndrome, Acta Neurol. Belg., 120, 595, 10.1007/s13760-018-01063-6 · DOI
- Musker, 2021, Circulating leptin levels in patients with myalgic encephalomyelitis, chronic fatigue syndrome or fibromyalgia: A systematic review protocol, JBI Evid. Synth., 19, 695, 10.11124/JBIES-20-00125 · DOI
- 2018, The association of IGF-1 with clinical symptoms in female patients with fibromyalgia syndrome, Ank. Med. J., 18, 410
- Marchand, 2012, Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments?, Open Rheumatol. J., 6, 296, 10.2174/1874312901206010296 · DOI
- Gupta, 2004, Psychological stress and fibromyalgia: A review of the evidence suggesting a neuroendocrine link, Arthritis Res. Ther., 6, 98, 10.1186/ar1176 · DOI
- Koca, 2019, The Importance of G-protein Coupled Estrogen Receptor in Patients with Fibromyalgia, Arch. Rheumatol., 34, 419, 10.5606/ArchRheumatol.2019.7236 · DOI
- Littlejohn, 2018, Neurogenic inflammation in fibromyalgia, Semin. Immunopathol., 40, 291, 10.1007/s00281-018-0672-2 · DOI · Paper page
- Sturgill, 2014, Unique cytokine signature in the plasma of patients with fibromyalgia, J. Immunol. Res., 2014, 938576, 10.1155/2014/938576 · DOI
- Mendieta, 2016, IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients, J. Neuroimmunol., 290, 22, 10.1016/j.jneuroim.2015.11.011 · DOI · Paper page
- Srivastava, 2021, Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis, Rheumatology, 60, 2602, 10.1093/rheumatology/keab146 · DOI · Paper page
- Mastrangelo, 2018, Low-grade chronic inflammation mediated by mast cells in fibromyalgia: Role of IL-37, J. Biol. Regul. Homeost. Agents., 32, 195
- Coskun, 2019, Role of inflammation in the pathogenesis and treatment of fibromyalgia, Rheumatol. Int., 39, 781, 10.1007/s00296-019-04251-6 · DOI
- Buskila, 2008, Etiology of fibromyalgia: The possible role of infection and vaccination, Autoimmun. Rev., 8, 41, 10.1016/j.autrev.2008.07.023 · DOI
- Fitzcharles, 2014, Adjudication of fibromyalgia syndrome: Challenges in the medicolegal arena, Pain Res. Manag., 19, 287, 10.1155/2014/742830 · DOI
- Clauw, 2003, Unexplained symptoms after terrorism and war: An expert consensus statement, J. Occup. Environ. Med., 45, 1040, 10.1097/01.jom.0000091693.43121.2f · DOI
- Hunskar, 2021, Prevalence of fibromyalgia 10 years after infection with Giardia lamblia: A controlled prospective cohort study, Scand. J. Pain, 22, 348, 10.1515/sjpain-2021-0122 · DOI
- Giesecke, 2005, The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort, Arthritis Rheum., 52, 1577, 10.1002/art.21008 · DOI · Paper page
- Epstein, 1999, Psychiatric disorders in patients with fibromyalgia: A multicenter investigation, Psychosomatics, 40, 57, 10.1016/S0033-3182(99)71272-7 · DOI · Paper page
- Cohen, 2002, Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits, Arthritis Rheum., 46, 845, 10.1002/art.10103 · DOI · Paper page
- Tong, R.L., Kahn, U.N., Grafe, L.A., Hitti, F.L., Fried, N.T., and Corbett, B.F. (2023). Stress circuitry: Mechanisms behind nervous and immune system communication that influence behavior. Front. Psychiatry, 14. · DOI
- Kleinman, 2014, Assessment of sleep in patients with fibromyalgia: Qualitative development of the fibromyalgia sleep diary, Health Qual. Life Outcomes, 12, 111, 10.1186/s12955-014-0111-6 · DOI
- Vijayan, 2015, Thalamic mechanisms underlying alpha-delta sleep with implications for fibromyalgia, J. Neurophysiol., 114, 1923, 10.1152/jn.00280.2015 · DOI
- Durkin, 2019, How sleep shapes thalamocortical circuitfunction in the visual system, Annu. Rev. Vis. Sci., 5, 295, 10.1146/annurev-vision-091718-014715 · DOI
- Flodin, 2014, Fibromyalgia is associated with decreased connectivity between pain- and sensorimotor brain areas, Brain Connect., 4, 587, 10.1089/brain.2014.0274 · DOI
- Keskindag, 2017, The association between pain and sleep in fibromyalgia, Saudi Med. J., 38, 465, 10.15537/smj.2017.5.17864 · DOI
- Hamilton, 2008, Fibromyalgia: The role of sleep-in affect and in negative event reactivity and recovery, Health Psychol., 27, 490, 10.1037/0278-6133.27.4.490 · DOI · Paper page
- Furness, 2018, What cause fibromyalgia? An online survey of patient perspectives, Health Psychol Open, 5, 2055102918802683, 10.1177/2055102918802683 · DOI
- Wolfe, 1990, The American College of Rheumatology 1990 criteria for classification of fibromyalgia. Report of the multicenter criteria committee, Arthritis Rheum., 33, 160, 10.1002/art.1780330203 · DOI · Paper page
- Motaqi, 2020, Trigger and Tender Points (Definitions, Similarities, Differences, Treatments), Int. J. Musculoskelet. Pain Prev., 5, 393, 10.52547/ijmpp.5.4.393 · doi:10.52547/ijmpp.5.4.393
- Stein, 1996, Trigger points and tender points: One and the same? Does injection treatment help?, Rheum. Dis. Clin. N. Am., 22, 305, 10.1016/S0889-857X(05)70274-X · doi:10.1016/s0889-857x(05)70274-x
- Arnold, 2018, AAPT diagnostic criteria for fibromyalgia, J. Pain, 20, 611, 10.1016/j.jpain.2018.10.008 · DOI · Paper page
- Baron, 2014, Improving the primary care physicians’ decision making for fibromyalgia in clinical practice: Development and validation of the fibromyalgia detection (FibroDetect®) screening tool, Health Qual. Life Outcomes, 12, 128, 10.1186/s12955-014-0128-x · DOI
- Salaffi, 2009, Development and validation of the self-administered Fibromyalgia Assessment Status: A disease-specific composite measure for evaluating treatment effect, Arthritis Res. Ther., 11, R125, 10.1186/ar2792 · DOI
- Iannuccelli, 2011, Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: A national web-based study of fibromyalgia, Clin. Exp. Rheumatol., 29, S49
- Macfarlane, 2017, EULAR revised recommendations for the management of fibromyalgia, Ann. Rheum. Dis., 76, 318, 10.1136/annrheumdis-2016-209724 · DOI · Paper page
- Calandre, 2015, An update on pharmacotherapy for the treatment of fibromyalgia, Expert. Opin. Pharmacother., 16, 1347, 10.1517/14656566.2015.1047343 · DOI
- Alciati, 2018, Controlled-release pregabalin in the treatment of fibromyalgia, Expert Rev. Neurother., 18, 617, 10.1080/14737175.2018.1508344 · DOI
- Littlejohn, 2016, Is there a role for opioids in the treatment ofb fibromyalgia?, Pain Manag., 6, 347, 10.2217/pmt-2016-0012 · DOI
- Clauw, 2017, The role of centralised pain in osteoarthritis, Clin. Exp. Rheumatol., 35, S79
- Busch, 2007, Exercise for treating fibromyalgia syndrome, Cochrane Database Syst. Rev., 17, CD003786
- Maguire, 2019, Behaviour change interventions targeting physical activity in adults with fibromyalgia: A systematic review, Rheumatol. Int., 39, 805, 10.1007/s00296-019-04270-3 · DOI
- Sun, 2022, Repetitive Transcranial Magnetic Stimulation for Patients with Fibromyalgia: A Systematic Review with Meta-Analysis, Pain Med., 23, 499, 10.1093/pm/pnab276 · DOI
- Moshfeghinia, R., Shekouh, D., Mostafavi, S., Hosseinzadeh, M., Bahadori, A.R., Abdollahifard, S., and Razmkon, A. (2023). The effects of transcranial direct-current stimulation (tDCS) on pain intensity of patients with fibromyalgia: A systematic review and meta-analysis. BMC Neurol., 23. · DOI
- Ansari, 2021, Fibromyalgia pain and depression: An update on the role of repetitive transcranial magnetic stimulation, ACS Chem. Neurosci., 12, 256, 10.1021/acschemneuro.0c00785 · DOI
- Teixeira, 2023, The Analgesic Effect of Transcranial Direct Current Stimulation in Fibromyalgia: A Systematic Review, Meta-Analysis, and Meta-Regression of Potential Influencers of Clinical Effect, Neuromodulation, 26, 715, 10.1016/j.neurom.2022.10.044 · DOI
Cited by
Okui, N., Ichino, K., Ide, H., Matsushita, K., Ikehata, Y., Okui, M., & Horie, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-58586-9
Metadata
- Authors
- Filipovic, T., Filipović, A., Nikolic, D., Gimigliano, F., Stevanov, J., Hrkovic, M., & Bosanac, I.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2025-02-02
- Volume
- 14
- Issue
- 3
- Pages
- 955
- ISSN
- 2077-0383
- Cited by
- 47
- References
- 19
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.